Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting HER2 heterogeneity in breast cancer.
Hamilton E, Shastry M, Shiller SM, Ren R. Hamilton E, et al. Among authors: shastry m. Cancer Treat Rev. 2021 Nov;100:102286. doi: 10.1016/j.ctrv.2021.102286. Epub 2021 Sep 2. Cancer Treat Rev. 2021. PMID: 34534820 Review.
Rise of Antibody-Drug Conjugates: The Present and Future.
Shastry M, Gupta A, Chandarlapaty S, Young M, Powles T, Hamilton E. Shastry M, et al. Am Soc Clin Oncol Educ Book. 2023 May;43:e390094. doi: 10.1200/EDBK_390094. Am Soc Clin Oncol Educ Book. 2023. PMID: 37229614 Free article.
Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer.
Yardley DA, Raefsky E, Castillo R, Lahiry A, Locicero R, Thompson D, Shastry M, Burris HA 3rd, Hainsworth JD. Yardley DA, et al. Among authors: shastry m. Clin Breast Cancer. 2011 Oct;11(5):297-305. doi: 10.1016/j.clbc.2011.04.002. Epub 2011 May 5. Clin Breast Cancer. 2011. PMID: 21729666 Clinical Trial.
58 results